image image

ApoCell has joined Precision for Medicine

Together, Precision and ApoCell provide a unique and comprehensive suite of specialty services and translational sciences solutions, from data management and biomarker analytics capabilities to liquid biopsies and tissue profiling.

BIOmarker discovery

We provide customized biomarker solutions to biopharma for accelerated drug development using integrated platform technologies.


Our Services

Platform Technologies
Assay Development
Circulating Tumor Cells
Flow Cytometry
Immunofluorescence Image Analysis
Cytokine Profiling
Clinical Sample Processing Services
Strategic Alliances

Areas of Expertise

Liquid Biopsy

ApoCell offers a comprehensive approach to using liquid biopsies (CTCs, ctDNA, exosomes) to detect and monitor multiple biomarkers using less sample.

Learn More

Clinical Trial Support

ApoCell provides biomarker design, sample collection and logistics support, and esoteric testing services across multiple therapeutic areas.

Learn More


ApoCell’s integrated platform technologies help advance immuno-oncology drug candidates from pre-clinical discovery through phase III clinical trials.

Companion Diagnostics

ApoCell’s biomarker-based assays can form the basis for laboratory developed tests and IVDs enhancing therapeutic outcomes.

Learn More

Learn more about how we can help you

Utilize biomarker testing strategies to advance your clinical pipeline.

Who We Help



ApoCell uses integrated platform technologies to help biopharmaceutical companies advance drug candidates through clinical trials and into the hands of doctors.


Academia & Government

ApoCell supports academic & government labs with our wide array of biomarker testing services, enabling more efficient and effective research.



Our focus is moving drug candidates through clinical trials so patients can begin benefiting from these experimental therapies.


Contract Research Organizations

ApoCell partners with contract research organizations to provide clinical trial support services including study documentation, sample logistics, and biomarker testing services.

Case Study

Pharmacodynamic Analysis of DNA Damage Biomarkers in CTCs as Part of the Phase III BEACON Trial in Breast Cancer


Services Partnerships

ApoCell partners with organizations involved in accelerating the process of therapeutic development and patient care, including CROs, other analytical labs, and patient advocacy groups.

ApoStream Partnership

ApoCell is seeking strategic partners for commercialization of its proprietary technology for use in various applications, including oncology, infectious disease, fetal cells, viable cell preservation, bacterial monitoring, regenerative medicine, and therapeutic manufacturing.